243 related articles for article (PubMed ID: 1647078)
1. Glycosylation of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 1 affects its functional but not its antigenic properties.
Gorman WL; Pridgen C; Portner A
Virology; 1991 Jul; 183(1):83-90. PubMed ID: 1647078
[TBL] [Abstract][Full Text] [Related]
2. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity.
Gorman WL; Gill DS; Scroggs RA; Portner A
Virology; 1990 Mar; 175(1):211-21. PubMed ID: 1689918
[TBL] [Abstract][Full Text] [Related]
3. Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein.
Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang Z
Virus Res; 2013 Jun; 174(1-2):137-47. PubMed ID: 23562646
[TBL] [Abstract][Full Text] [Related]
4. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
Mishin VP; Watanabe M; Taylor G; Devincenzo J; Bose M; Portner A; Alymova IV
J Virol; 2010 Mar; 84(6):3094-100. PubMed ID: 20053750
[TBL] [Abstract][Full Text] [Related]
5. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion.
Bousse T; Takimoto T; Gorman WL; Takahashi T; Portner A
Virology; 1994 Nov; 204(2):506-14. PubMed ID: 7941317
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation contributes to the limited cross-reactivity between hemagglutinin neuraminidase proteins of human parainfluenza virus type 4A and 4B.
Komada H; Ito M; Nishio M; Kawano M; Ohta H; Tsurudome M; Kusagawa S; O'Brien M; Bando H; Ito Y
Med Microbiol Immunol; 2000 Sep; 189(1):1-6. PubMed ID: 11034551
[TBL] [Abstract][Full Text] [Related]
7. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus.
Portner A; Scroggs RA; Metzger DW
Virology; 1987 May; 158(1):61-8. PubMed ID: 2437698
[TBL] [Abstract][Full Text] [Related]
8. Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants.
Thompson SD; Portner A
Virology; 1987 Sep; 160(1):1-8. PubMed ID: 2820122
[TBL] [Abstract][Full Text] [Related]
9. Antigenic diversity of human parainfluenza virus type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies.
Komada H; Kusagawa S; Orvell C; Tsurudome M; Nishio M; Bando H; Kawano M; Matsumura H; Norrby E; Ito Y
J Gen Virol; 1992 Apr; 73 ( Pt 4)():875-84. PubMed ID: 1378879
[TBL] [Abstract][Full Text] [Related]
10. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M
Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732
[TBL] [Abstract][Full Text] [Related]
11. The human parainfluenza virus type-1 prototypic strain contains a heat-labile hemagglutinin-neuraminidase protein.
Takimoto T; Portner A
Virus Res; 1994 Apr; 32(1):85-92. PubMed ID: 8030367
[TBL] [Abstract][Full Text] [Related]
12. Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.
Alymova IV; Taylor G; Mishin VP; Watanabe M; Murti KG; Boyd K; Chand P; Babu YS; Portner A
J Virol; 2008 Sep; 82(17):8400-10. PubMed ID: 18579600
[TBL] [Abstract][Full Text] [Related]
13. The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of Sendai virus from infected cells.
Orvell C; Kristensson K
Arch Virol; 1985; 86(1-2):1-15. PubMed ID: 2994598
[TBL] [Abstract][Full Text] [Related]
14. Identification of amino acid positions associated with neuraminidase activity of the hemagglutinin-neuraminidase glycoprotein of Sendai virus.
Gorman WL; Takahashi T; Scroggs RA; Portner A
Virology; 1991 Feb; 180(2):803-8. PubMed ID: 1846501
[TBL] [Abstract][Full Text] [Related]
15. Structural Insights into Human Parainfluenza Virus 3 Hemagglutinin-Neuraminidase Using Unsaturated 3- N-Substituted Sialic Acids as Probes.
Pascolutti M; Dirr L; Guillon P; Van Den Bergh A; Ve T; Thomson RJ; von Itzstein M
ACS Chem Biol; 2018 Jun; 13(6):1544-1550. PubMed ID: 29693380
[TBL] [Abstract][Full Text] [Related]
16. Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors.
Eveno T; Dirr L; El-Deeb IM; Guillon P; von Itzstein M
Viruses; 2019 May; 11(5):. PubMed ID: 31060278
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.
van Wyke Coelingh KL; Winter CC; Jorgensen ED; Murphy BR
J Virol; 1987 May; 61(5):1473-7. PubMed ID: 2437318
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of soluble human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.
Wang ZM; Tong LL; Grant D; Cihlar T
J Virol Methods; 2001 Oct; 98(1):53-61. PubMed ID: 11543884
[TBL] [Abstract][Full Text] [Related]
19. Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages.
Hetherington SV; Watson AS; Scroggs RA; Portner A
J Infect Dis; 1994 Feb; 169(2):248-52. PubMed ID: 7508966
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates.
Henrickson KJ
J Infect Dis; 1991 Dec; 164(6):1128-34. PubMed ID: 1659598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
